Abstract Coronavirus disease 2019 (COVID-19) is a devastating viral infection caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The incidence and …

As the global COVID-19 pandemic spreads worldwide, new challenges arise in the clinical
landscape. The need for reliable diagnostic methods, treatments and vaccines for COVID-19 …

During the coronavirus disease-2019 (COVID-19) pandemic there were several barriers to
treatment access and medication adherence in rheumatoid arthritis (RA) patients. There is …

Background Sargramostim [recombinant human granulocyte-macrophage colony-
stimulating factor (rhu GM-CSF)] was approved by US FDA in 1991 to accelerate bone …

Patients with heart failure (HF) who contract SARS‐CoV‐2 infection are at a higher risk of
cardiovascular and non‐cardiovascular morbidity and mortality. Regardless of therapeutic …

SARS-CoV-2 causing coronavirus disease 2019 (COVID-19) has wreaked havoc during the
global pandemic of 2020 infecting millions and leaving over a half million dead. As a new …

In December 2019, a small number of cases of pneumonia of unknown origin were
recognized in the city of Wuhan, China. Soon, the disease, whose etiological factor was …

The COVID‐19 pandemic has led to the biggest global health crisis of our lifetime. There is
accumulating evidence that a substantial number of critically ill COVID‐19 patients exhibit a …

Background: Long-term perspective of COVID-19 including the interaction between
persisting viral-RNA and specific tissue involvement is a challenging issue. In this study, we …

The dysfunctional effects of the coronavirus disease 2019 (COVID-19) infection on the
nervous system are established. The manifestation of neuropsychiatric symptoms during …